Latest filing published 11 Mar 2026 for Natco Pharma Limited, €420k.
Satya Vani Nannapaneni is a declared insider of Natco Pharma Limited, with filings sourced from SEBI (PIT + SAST). Between 28 February 2025 and 9 March 2026, the trades on record add up to 4 filings.
On the market, this insider has only sold: 3 sales, €749k in total. Since January 2026: no purchases and 1 sale on the market.
Most recently, on 11 March 2026, the filings show an open-market sale worth €420k in Natco Pharma Limited. Filings reach the SEBI (PIT + SAST) feed a median of 2 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations